Research

An antibody that was invented at UNC Charlotte could be used to curb pancreatic cancer relapse and metastasis, a new UNC Charlotte study has found. Pancreatic cancer is particularly cruel  — and deadly. Yet, there is hope for improved treatment options. UNC Charlotte researchers are among those leading the search for solutions, including research by Mukulika Bose ’22 Ph.D. and collaborators, including Bose’s mentor Pinku Mukherjee, published in the journal Translational Research.

The research of Associate Professor Dr. Menelaos Poutous has recently been highlighted by The International Society for Optics and Photonics due to the valuable insights it offers surrounding the fabrication of diffraction gradings. The paper, published by Dr. Poutous and Dr. Hanshin Lee of the University of Texas at Austin in October of this year, […]

Dr. Danillo Augusto is the winner of the 2022 Early Career Investigator Award of the American Society for Histocompatibility & Immunogenics and its Science & Technology Initiatives Committee (STIC) The aim of the ASHI Early Career Investigator Award (ECIA) is to identify future research leaders who are committed to conducting impactful basic science research. This […]

Charlotte researcher Rosario Porras-Aguilar, whose work includes a focus on learning how cancers spread, is one of 21 early career scientists in the United States and Canada to win funding and other support through the Scialog: Advancing BioImaging initiative.

Charlotte researcher Rosario Porras-Aguilar, whose work includes a focus on learning how cancers spread, is one of 21 early career scientists in the United States and Canada to win funding and other support through the Scialog: Advancing BioImaging initiative. Scialog aims to accelerate the development of the next generation of imaging technologies. Porras-Aguilar, an assistant […]

A new biomolecular anticoagulant platform invented by a team led by UNC Charlotte researcher Kirill Afonin holds promise as a revolutionary advancement over the blood thinners currently used during surgeries and other procedures. While blood clotting is important to prevent blood loss and for our immunity, coagulation also can cause health issues and even death. Anticoagulants used to reduce risks can also cause significant issues, such as uncontrolled bleeding.

Corals are keystone species for reef and marine ecosystems, but coral bleaching due to climate change and ocean warming is killing them. A new open access study led by researchers at UNC Charlotte and the University of California, Riverside aims to shed light on how to reverse the damage and save corals. Tingting Xiang, an assistant professor of biological sciences at UNC Charlotte, also is faculty with the university’s CIPHER research center.

The National Cancer Institute (NCI) is showcasing nanotechnology particles designed and produced by leading UNC Charlotte researcher Kirill Afonin’s lab on the cover of a document presented to the U.S. House and Senate appropriations committees. NCI is the principal federal agency for cancer research and training.

For UNC Charlotte biochemist Andrew Truman, a quest for new and better treatments for cancers and neurological diseases drives his research into protein folding and the DNA damage response, along with his desire to advance science broadly. To fund his work, he has received three significant National Institutes of Health (NIH) grants expected to total $2M. “These are real things that affect real people. They are not theoretical,” Truman says.

For over a decade, researchers and students in UNC Charlotte’s Center for Metamaterials have studied and created materials that can bend, absorb, transmit, and otherwise manipulate light and sound waves that pass through them. The center has joined a select group of such centers to earn a third phase of National Science Foundation (NSF) funding.